Lancet Seminar provides an in-depth review on the risk for sudden unexpected death in patients with epilepsy and offers advice to clinicians on ways to minimize the risk. br / iMedscape Medical News/i
Clobazam was recently approved for seizures associated with Lennox-Gastaut syndrome. Dr. Andrew Wilner discusses the clinical role of the agent. Medscape Neurology
The 8th International Conference on Pain and Chemical Dependency offered new information on tools for pain and opioid abuse risk assessment. Medscape Neurology & Neurosurgery
The investigational oral drug BG-12 may be a valuable treatment option for patients with MS, combining strong efficacy, a favorable safety profile, and oral administration, researchers say. Medscape Medical News
Researchers have uncovered a genetic defect in the histidine decarboxylase gene that may underlie Tourette?s syndrome in a 2-generation pedigree. Medscape Medical News
A new study shows that carbamazepine increased hepatic metabolism in mentally ill smokers, leading to concerns that these medications may increase nicotine cravings and hamper cessation efforts. Medscape Medical News
